Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Diagnostic value of antibody responses to Mycobacterium avium subsp. paratuberculosis-derived proteins PtpA and PtpB in rheumatoid arthritis.

PloS one·2026
Same author

CEST MRI in the Management/Diagnosis of Neuroinfectious Diseases.

International journal of molecular sciences·2025
Same author

Current treatments and the future of nanomedicine in hepatitis C.

Nanomedicine (London, England)·2025
Same author

AgNP-Containing Niosomes Functionalized with Fucoidan Potentiated the Intracellular Killing of <i>Mycobacterium abscessus</i> in Macrophages.

International journal of molecular sciences·2025
Same author

Assessing the efficacy of nanoparticles in reversing opioid poisoning and preventing renarcotization.

Nanomedicine (London, England)·2025
Same author

PtpA protein from Mycobacterium avium subsp. paratuberculosis as a potential marker of rheumatoid arthritis in humans.

PloS one·2025

Related Experiment Video

Updated: Oct 22, 2025

Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer
11:31

Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer

Published on: May 20, 2016

10.9K

Current and Future Development in Lung Cancer Diagnosis.

Reem Nooreldeen1, Horacio Bach1

  • 1Division of Infectious Diseases, Faculty of Medicine, The University of British Columbia, Vancouver, BC V6H 3Z6, Canada.

International Journal of Molecular Sciences
|August 27, 2021
PubMed
Summary

Early lung cancer diagnosis is critical, especially for high-risk individuals. This review explores novel biomarkers in body fluids to improve early detection, overcoming limitations of current imaging and biopsy methods.

Keywords:
biomarkersbody fluidsdiagnosisimaginglung cancerpredictors

More Related Videos

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.3K
Detection of Lung Tumor Progression in Mice by Ultrasound Imaging
04:43

Detection of Lung Tumor Progression in Mice by Ultrasound Imaging

Published on: February 27, 2020

7.0K

Related Experiment Videos

Last Updated: Oct 22, 2025

Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer
11:31

Using Micro-computed Tomography for the Assessment of Tumor Development and Follow-up of Response to Treatment in a Mouse Model of Lung Cancer

Published on: May 20, 2016

10.9K
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.3K
Detection of Lung Tumor Progression in Mice by Ultrasound Imaging
04:43

Detection of Lung Tumor Progression in Mice by Ultrasound Imaging

Published on: February 27, 2020

7.0K

Area of Science:

  • Oncology
  • Biomarker Discovery
  • Diagnostic Medicine

Background:

  • Lung cancer is a leading cause of cancer mortality globally.
  • Delayed diagnosis, often at advanced stages, contributes to poor outcomes.
  • Current diagnostic methods like imaging and biopsies struggle with early detection.

Purpose of the Study:

  • To review current lung cancer diagnostic methods, highlighting their pros and cons.
  • To analyze the potential of body fluids as a source for novel biomarkers.
  • To emphasize the urgent need for improved early detection strategies.

Main Methods:

  • Literature review of existing lung cancer diagnostic techniques.
  • Analysis of studies investigating biomarkers in various body fluids.
  • Comparative assessment of traditional versus emerging diagnostic approaches.

Main Results:

  • Current diagnostic tools have limitations in detecting early-stage lung cancer.
  • Body fluids show promise as accessible sources for cancer biomarkers.
  • Novel biomarkers could significantly enhance early detection and patient outcomes.

Conclusions:

  • There is a critical need for novel biomarkers for early lung cancer detection.
  • Investigating biomarkers in body fluids offers a promising avenue for improved diagnostics.
  • Enhanced early detection through biomarkers can improve survival rates for lung cancer patients.